Quanterix Agrees to Buy Life Sciences Firm Akoya Biosciences (1)

Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies that detect diseases at different stages of progression.

Akoya investors will receive 0.318 Quanterix shares for each Akoya share they own, according to a statement Friday, which confirmed an earlier Bloomberg News report. The offer represents a 19% premium to Akoya’s share price on Nov. 14, before the company announced a review of strategic alternatives.

The combined company’s equity will be worth about $670 million, according to a spokesperson for Quanterix.

Shares of Akoya have lost nearly half their value in ...